サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1798241

サルコペニア治療の世界市場

Sarcopenia Treatment

出版日
ページ情報
英文 277 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.02円
サルコペニア治療の世界市場
出版日: 2025年08月26日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 277 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

サルコペニア治療の世界市場は2030年までに36億米ドルに達する

2024年に30億米ドルと推定されるサルコペニア治療の世界市場は、2024年から2030年にかけてCAGR 3.2%で成長し、2030年には36億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるビタミンD・カルシウムサプリメントは、CAGR 4.4%を記録し、分析期間終了時には16億米ドルに達すると予測されます。プロテインサプリメント分野の成長率は、分析期間中CAGR 2.1%と推定されます。

米国市場は8億1,180万米ドルと推定される一方、中国はCAGR 6.2％で成長すると予測される

米国のサルコペニア治療市場は、2024年に8億1,180万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7億1,850万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.1%と2.5%と予測されています。欧州では、ドイツがCAGR 1.8%で成長すると予測されています。

世界のサルコペニア治療市場- 主要動向と促進要因まとめ

サルコペニアが高齢化社会における治療イノベーションの重要なターゲットとして浮上しているのはなぜか？

進行性の骨格筋減少と機能障害を特徴とするサルコペニアは、単なる老化の製品別ではなく、独立した臨床的実体として急速に注目を集めています。虚弱に関連した入院リスク、運動能力の低下、高齢者介護の経済的負担に対する認識が高まるにつれ、ヘルスケアシステムはサルコペニアの早期発見と治療をますます優先するようになっています。サルコペニアは、ICD-10コーディングシステムによって正式に認知され、米国、欧州、日本の老年リスク評価に含まれるようになりました。このような規制による認知は、臨床研究、診断開発、サルコペニア特有の病態生理に合わせた治療介入戦略を刺激しています。

現在の治療アプローチは、栄養補給や身体的リハビリテーションにとどまらず、筋同化作用やミトコンドリア機能を標的とした薬理学的薬剤を含むようになってきています。選択的アンドロゲン受容体モジュレーター（SARM）、ミオスタチン阻害剤、ミトコンドリア増強剤などの治験治療薬は、様々な臨床評価段階にあります。これらの候補薬は、筋タンパク質の合成を促進し、異化を抑制し、ミトコンドリアの効率を改善することを目的としており、これらすべてがサルコペニアの回復や進行の抑制に寄与します。さらに、いくつかのバイオテクノロジー新興企業が、RNA標的プラットフォームと代謝調節剤を活用して、ファースト・イン・クラスのサルコペニア特異的薬剤を開発しており、これは、この十分に対処されていない状態に対する投資家と研究者の関心の高まりを反映しています。

診断と患者層別化の進歩は治療開発をどのように形成しているか？

診断モダリティの進化は、その精度と範囲を大幅に向上させています。二重エネルギーX線吸収測定法（DXA）、生体電気インピーダンス分析法（BIA）、コンピュータ断層撮影法（CT）スキャンは、筋肉量の定量化だけでなく、治療結果の縦断的モニタリングにも使用されるようになっています。デジタル筋機能トラッカーや歩行分析ツールは、治療効果に関するより詳細で現実的なエビデンスを得るために臨床試験に組み込まれています。このような診断により、特に複数の合併症を持つ虚弱な高齢者集団では、画一的なアプローチでは効果がなく、個別化された治療レジメンが可能になりつつあります。

炎症性バイオマーカー、ホルモンバランスの乱れ、代謝リスクプロファイルに基づく患者層別化は、試験デザインと臨床実践に不可欠なものとなりつつあります。慢性的な低悪性度炎症、インスリン抵抗性、テストステロンやビタミンDの欠乏は、サルコペニアの主要なリスク増幅因子として現在認識されています。その結果、炎症性サルコペニアやがん患者の悪液質に伴う筋力低下など、特定の患者の表現型に合わせた治療アプローチが行われるようになってきています。このような進歩により、製薬会社や研究機関は、よりターゲットを絞った患者コホートを集め、メカニズムに特化した介入をデザインすることが可能となり、規制経路が加速され、臨床成功率が向上しています。

この多因子性疾患に対処するために、どのような治療アプローチが検討されているか？

サルコペニア治療パイプラインは、基本的な筋力強化にとどまらず、神経筋協調、代謝調節、ホルモンサポートに対処する多面的な戦略へと拡大しつつあります。enobosarm（GTx-024）やMK-0773のようなSARMは、初期の臨床試験で有望な同化作用を示し、bimagrumabのようなミオスタチン経路阻害剤や抗アクチビン受容体抗体は、筋分解シグナルを遮断する能力を試験中です。さらに、メトホルミンやミトコンドリア生合成促進剤などの代謝系薬剤も、筋肉量や筋力に対する間接的な効果を検討中です。

栄養補助食品と併用療法もまた、臨床的に注目を集めています。高ロイシン・ホエイタンパク質、オメガ3脂肪酸、ビタミンDを組み合わせた製剤は、相乗効果を調べるための長期的な研究で評価されています。このような組み合わせは、特に病院での回復期や、食事からのタンパク質摂取量が少ない高齢者において有効です。さらに、神経筋電気刺激（NMES）装置やロボットリハビリテーションシステムが、サルコペニアケアに導入され、運動能力の低下した患者の理学療法を補強しています。これらのハードウェアベースの介入は、パフォーマンスを記録し、治療の調整を導き、コンプライアンスを確保するためのデジタル追跡アプリと組み合わされています。

サルコペニア治療オプションの世界の成長を加速させている要因とは？

サルコペニア治療市場の成長は、世界人口の急速な高齢化、サルコペニアを疾患として認識する臨床の増加、予防老年医学へのシフトなど、いくつかの要因によって牽引されています。特に日本、イタリア、ドイツ、韓国などの国々では、平均寿命が延びるにつれて、サルコペニアに関連した障害が加齢に伴う医療費支出の主要な要因として浮上しています。医療保険者や政策立案者は、スクリーニング・プログラム、栄養補助、リハビリ・サービスに資金を提供することで早期介入戦略を支援しており、その結果、薬理学的治療や支持療法に対する下流の需要が生まれています。

さらに、臨床試験も勢いを増しており、筋力低下やサルコペニア関連のエンドポイントを対象とした研究が世界で100件以上登録されています。バイオファーマ企業は、創薬を加速させ、知識ベースを拡大するために、学術センターや老化研究機関と戦略的提携を結んでいます。FDAやEMAのような規制機関は、歩行速度や握力のような代替エンドポイントを考慮することに意欲を示しており、これにより試験期間を短縮し、より迅速な承認を促進することができます。さらに、コンパニオン診断薬やデジタルバイオマーカーが利用できるようになったことで、試験の精度や市販後のモニタリングが向上しています。

一般市民の意識の高まり、ウェアラブル技術の採用、高齢化対応ソリューションへの需要が、この市場をさらに後押ししています。バイオテクノロジー、診断学、リハビリテーション・システムの融合は、ケア環境全体にわたる包括的なサルコペニア管理プログラムの基盤を築きつつあります。高齢化社会の需要に対応するために医療システムが進化するにつれて、サルコペニア治療市場は世界中で投資、臨床採用、商業的拡大が加速する見通しです。

セグメント

治療タイプ（ビタミンD＆カルシウムサプリメント、タンパク質サプリメント、ビタミンB12サプリメント、その他の治療タイプ）、流通チャネル（病院薬局、小売薬局、オンライン流通チャネル、その他の流通チャネル）

調査対象企業の例

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Biophytis SA
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Endo International plc
  • GlaxoSmithKline plc
  • Hologic Inc.
  • Merck & Co., Inc.
  • MyoDyna AS
  • Novartis AG
  • Pfizer Inc.
  • Radius Health Inc.
  • Regeneron Pharmaceuticals
  • Sanofi
  • SARCO Biosystems Inc.
  • TSI Group Ltd.
  • Veru Inc.

AIインテグレーションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP39303

Global Sarcopenia Treatment Market to Reach US$3.6 Billion by 2030

The global market for Sarcopenia Treatment estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Vitamin D & Calcium Supplements, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Protein Supplements segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$811.8 Million While China is Forecast to Grow at 6.2% CAGR

The Sarcopenia Treatment market in the U.S. is estimated at US$811.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$718.5 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Sarcopenia Treatment Market - Key Trends & Drivers Summarized

Why Is Sarcopenia Emerging as a Critical Target for Therapeutic Innovation in Aging Populations?

Sarcopenia, characterized by progressive skeletal muscle loss and functional impairment, is rapidly gaining attention as a standalone clinical entity rather than just a byproduct of aging. With growing awareness about frailty-related hospitalization risks, mobility decline, and the economic burden of elderly care, healthcare systems are increasingly prioritizing early detection and treatment of sarcopenia. The condition has been officially recognized by the ICD-10 coding system and is now included in geriatric risk assessments across the U.S., Europe, and Japan. This regulatory recognition is catalyzing clinical research, diagnostic development, and therapeutic intervention strategies tailored to sarcopenia’s unique pathophysiology.

Current treatment approaches are moving beyond nutritional supplementation and physical rehabilitation to include pharmacological agents that target muscle anabolism and mitochondrial function. Investigational therapies such as selective androgen receptor modulators (SARMs), myostatin inhibitors, and mitochondrial enhancers are under various stages of clinical evaluation. These candidates aim to promote muscle protein synthesis, reduce catabolism, and improve mitochondrial efficiency-all of which contribute to reversing or slowing the progression of sarcopenia. Moreover, several biotech startups are leveraging RNA-targeted platforms and metabolic modulators to develop first-in-class sarcopenia-specific drugs, reflecting a growing investor and research interest in this under-addressed condition.

How Are Diagnostic and Patient Stratification Advances Shaping Therapeutic Development?

The evolution of diagnostic modalities is significantly enhancing the precision and scope of sarcopenia treatment. Dual-energy X-ray absorptiometry (DXA), bioelectrical impedance analysis (BIA), and computed tomography (CT) scans are now being used not only for muscle mass quantification but also for longitudinal monitoring of therapy outcomes. Digital muscle function trackers and gait analysis tools are being integrated into clinical trials to generate more granular, real-world evidence on treatment efficacy. These diagnostics are enabling personalized treatment regimens, particularly in frail elderly populations with multiple comorbidities where a one-size-fits-all approach is ineffective.

Patient stratification based on inflammatory biomarkers, hormonal imbalances, and metabolic risk profiles is becoming integral to trial design and clinical practice. Chronic low-grade inflammation, insulin resistance, and deficiencies in testosterone or vitamin D are now recognized as key risk amplifiers of sarcopenia. Consequently, treatment approaches are being tailored to specific patient phenotypes-such as inflammatory sarcopenia or cachexia-linked muscle wasting in cancer patients. These advances are allowing pharmaceutical companies and research institutions to recruit more targeted patient cohorts and design mechanism-specific interventions, accelerating regulatory pathways and improving clinical success rates.

What Therapeutic Approaches Are Being Explored to Address This Multifactorial Condition?

The therapeutic pipeline for sarcopenia is expanding beyond basic muscle enhancement to include multifaceted strategies addressing neuromuscular coordination, metabolic regulation, and hormonal support. SARMs such as enobosarm (GTx-024) and MK-0773 have demonstrated promising anabolic effects in early trials, while myostatin pathway inhibitors like bimagrumab and anti-activin receptor antibodies are being tested for their ability to block muscle degradation signals. Additionally, metabolic agents such as metformin and mitochondrial biogenesis boosters are under investigation for their indirect benefits on muscle mass and strength.

Nutraceuticals and combination therapies are also gaining clinical traction. Formulations combining high-leucine whey protein, omega-3 fatty acids, and vitamin D are being evaluated in long-term studies to determine synergistic benefits. These combinations are particularly relevant in post-hospital recovery settings and among older adults with low dietary protein intake. Furthermore, neuromuscular electrical stimulation (NMES) devices and robotic rehabilitation systems are being introduced in sarcopenia care to augment physical therapy in patients with limited mobility. These hardware-based interventions are being paired with digital tracking apps to record performance, guide therapy adjustments, and ensure compliance.

What Factors Are Accelerating the Global Growth of Sarcopenia Treatment Options?

The growth in the sarcopenia treatment market is driven by several factors, including the rapidly aging global population, increased clinical recognition of sarcopenia as a disease, and the shift toward preventive geriatrics. As life expectancy rises, sarcopenia-related disability is emerging as a leading contributor to age-related health expenditures, particularly in countries like Japan, Italy, Germany, and South Korea. Health insurers and policy makers are supporting early intervention strategies by funding screening programs, nutritional subsidies, and rehab services, which in turn create downstream demand for pharmacological and supportive care treatments.

Additionally, clinical trials are gaining momentum, with more than 100 studies registered globally targeting muscle wasting and sarcopenia-related endpoints. Biopharma companies are forming strategic collaborations with academic centers and aging research institutes to accelerate drug discovery and expand the knowledge base. Regulatory bodies like the FDA and EMA have expressed willingness to consider surrogate endpoints such as gait speed and grip strength, which can shorten trial durations and facilitate faster approvals. Moreover, the availability of companion diagnostics and digital biomarkers is enhancing trial precision and post-market monitoring.

Growing public awareness, wearable technology adoption, and demand for aging-in-place solutions are further propelling this market. The convergence of biotechnology, diagnostics, and rehabilitation systems is laying the foundation for comprehensive sarcopenia management programs across care settings. As health systems evolve to meet the demands of an aging population, the sarcopenia treatment market is poised to see accelerated investment, clinical adoption, and commercial expansion worldwide.

SCOPE OF STUDY:

The report analyzes the Sarcopenia Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements, Other Treatment Types); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Biophytis SA
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Endo International plc
  • GlaxoSmithKline plc
  • Hologic Inc.
  • Merck & Co., Inc.
  • MyoDyna AS
  • Novartis AG
  • Pfizer Inc.
  • Radius Health Inc.
  • Regeneron Pharmaceuticals
  • Sanofi
  • SARCO Biosystems Inc.
  • TSI Group Ltd.
  • Veru Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Sarcopenia Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Age-Related Muscle Loss Throws the Spotlight on Sarcopenia Treatment Market
    • Growth in Aging Global Population Propels Demand for Therapeutic and Preventive Interventions
    • Expansion of Geriatric Wellness and Frailty Clinics Drives Interest in Sarcopenia Treatment Pathways
    • Integration of Resistance Training With Nutritional Supplementation Strengthens Treatment Outcomes
    • Increased R&D in Myostatin Inhibitors and Anabolic Therapies Spurs Innovation in Drug Pipelines
    • Regulatory Recognition of Sarcopenia as a Disease Category Expands Scope for Clinical Trials
    • Growing Demand for Functional Mobility and Quality of Life Metrics Drives Personalized Therapies
    • Advancements in Muscle Mass Assessment Techniques Boost Early Diagnosis and Intervention Rates
    • Rising Use of Amino Acid-Based Supplements Accelerates Adoption in Community Health Programs
    • Pharma Partnerships With Academic Institutions Fuel Biomarker Discovery and Target Validation
    • Increased Awareness Among Primary Care Physicians Spurs Early Identification and Treatment Referrals
    • Use of Digital Health Platforms and Wearables Enhances Patient Monitoring and Treatment Adherence
    • Expansion of Gait and Strength Assessment Tools Propels Reimbursement for Sarcopenia Screening
    • OEM Innovation in Exoskeletons and Assistive Mobility Devices Enhances Non-Pharmaceutical Interventions
    • Shift Toward Multidisciplinary Treatment Approaches Strengthens Role of Physiotherapy in Sarcopenia Care
    • Growing Evidence Linking Sarcopenia With Chronic Diseases Drives Inclusion in Comorbidity Management
    • Rise of Nutraceutical and Functional Food Products Targets Muscle Health in Aging Populations
    • Launch of Combination Therapies and Dual-Mechanism Agents Expands Clinical Efficacy Options
    • Health Insurance Reforms and Aging-In-Place Programs Propel Access to Sarcopenia Treatments
    • Clinical Validation of Testosterone Modulators and SARMs Creates New Therapeutic Pathways
    • Growing Adoption of Tele-Rehabilitation Models Sustains Remote Engagement in Muscle Maintenance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sarcopenia Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sarcopenia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vitamin D & Calcium Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vitamin D & Calcium Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Vitamin D & Calcium Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Protein Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Protein Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Protein Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vitamin B12 Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vitamin B12 Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Vitamin B12 Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • JAPAN
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CHINA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • EUROPE
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Sarcopenia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • FRANCE
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • GERMANY
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Sarcopenia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • INDIA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Sarcopenia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Sarcopenia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AFRICA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030

IV. COMPETITION